Alembic Pharmaceuticals Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

11:45 AM, 13th Nov 2025

Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dexlansoprazole Delayed-Release Capsules 30mg and 60 mg.